InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Myers Robert l. Director active across 2 companies, notably Predictive Oncology Inc.. Cumulatively, 6 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €9k. History available since 23 September 2021. The latest transaction was disclosed on 2 December 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Myers Robert l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
1,667 股Common StockSEC:0001171843-23-005892:0
8,795 股@ US$0.56866.5% 占其流量Common StockSEC:0001415889-22-011944:0
标准退出：2023年3月2日 (T+90)
33,333 股Common StockSEC:0001415889-22-009970:0
16,125 股@ US$0.303211.1% 占其流量Common StockSEC:0001415889-22-005364:0
标准退出：2022年8月18日 (T+90)
33,334 股@ US$1.1377.4% 占其流量Common Stock, $.01 par valueSEC:0001179110-21-008909:0
15,685 股Common StockSEC:0001179110-16-017475:0
6 条申报中的 6 条
About Myers Robert l
MYERS ROBERT L is a chief financial officer at Predictive Oncology Inc. and Skyline Medical Inc. The 7 filings recorded, all within the full sample held, cover the period from 2016-01-07 to 2023-09-27 and show EUR 9371 of purchases and EUR 0 of sales, with option exercise as the most common transaction nature.
